Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 22, 2023, by Cellectis S.A., a foreign private issuer, serves to announce the scheduling of the Company's Combined General Meeting of Shareholders. The meeting is set for June 27, 2023, at 2:30 p.m. Paris time, to be held at the Biopark auditorium in Paris, France.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely references the attached Notice of Combined General Meeting of Shareholders.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly notifies shareholders of the upcoming meeting date, time, and location, incorporating the Notice of Meeting as an exhibit.
Key Facts for Investors to Verify
- Confirm the date and time of the Combined General Meeting of Shareholders: June 27, 2023, at 2:30 p.m. Paris time.
- Verify the meeting location: Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.
- Review the attached Exhibit 99.1 (Notice of Combined General Meeting of Shareholders) for specific resolutions to be voted upon.
- Note that this filing does not include updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.